Niklas Zojer

4.7k total citations
125 papers, 2.7k citations indexed

About

Niklas Zojer is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Niklas Zojer has authored 125 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hematology, 66 papers in Molecular Biology and 38 papers in Oncology. Recurrent topics in Niklas Zojer's work include Multiple Myeloma Research and Treatments (86 papers), Protein Degradation and Inhibitors (25 papers) and Glycosylation and Glycoproteins Research (16 papers). Niklas Zojer is often cited by papers focused on Multiple Myeloma Research and Treatments (86 papers), Protein Degradation and Inhibitors (25 papers) and Glycosylation and Glycoproteins Research (16 papers). Niklas Zojer collaborates with scholars based in Austria, Germany and Czechia. Niklas Zojer's co-authors include Heinz Ludwig, Johannes Drach, Heinz Gisslinger, Michael Fiegl, H. Huber, Jutta Ackermann, R. Heinz, H. Kaufmann, Elisabeth Krömer and Arnold Bolomsky and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Niklas Zojer

116 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Niklas Zojer 1.8k 1.7k 1.1k 474 263 125 2.7k
Peter Gimsing 2.1k 1.2× 1.9k 1.1× 1.4k 1.2× 301 0.6× 324 1.2× 111 3.1k
Paola Omedè 1.7k 1.0× 1.3k 0.7× 1.0k 0.9× 508 1.1× 553 2.1× 112 2.7k
Jatin J. Shah 2.0k 1.1× 2.4k 1.3× 1.6k 1.4× 417 0.9× 331 1.3× 208 3.8k
Dixie Esseltine 1.9k 1.1× 1.8k 1.0× 1.6k 1.4× 539 1.1× 230 0.9× 44 3.1k
Cristina Papayannidis 1.4k 0.8× 1.0k 0.6× 882 0.8× 508 1.1× 207 0.8× 160 2.7k
Michael J. Thirman 2.4k 1.4× 2.3k 1.3× 559 0.5× 671 1.4× 296 1.1× 90 4.0k
Sonia Fabris 1.0k 0.6× 1.8k 1.0× 646 0.6× 553 1.2× 248 0.9× 93 2.8k
Simrit Parmar 1.6k 0.9× 1.3k 0.7× 1.0k 0.9× 466 1.0× 963 3.7× 167 2.9k
Toshiko Motoji 1.5k 0.9× 915 0.5× 578 0.5× 700 1.5× 399 1.5× 121 2.6k
Akil Merchant 818 0.5× 1.5k 0.8× 836 0.7× 226 0.5× 333 1.3× 84 2.5k

Countries citing papers authored by Niklas Zojer

Since Specialization
Citations

This map shows the geographic impact of Niklas Zojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Zojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Zojer more than expected).

Fields of papers citing papers by Niklas Zojer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklas Zojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Zojer. The network helps show where Niklas Zojer may publish in the future.

Co-authorship network of co-authors of Niklas Zojer

This figure shows the co-authorship network connecting the top 25 collaborators of Niklas Zojer. A scholar is included among the top collaborators of Niklas Zojer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niklas Zojer. Niklas Zojer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bolomsky, Arnold, Roy Heusschen, Joséphine Muller, et al.. (2017). Preclinical Evaluation of the First in Class BMI1 Inhibitor PTC-028 Confirms Potent Efficacy to Target BMI1-Addiction in Multiple Myeloma. Blood. 130. 1804–1804. 1 indexed citations
3.
4.
Bolomsky, Arnold, Roy Heusschen, Karin Schlangen, et al.. (2017). Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma. Haematologica. 103(2). 325–335. 24 indexed citations
5.
Bolomsky, Arnold, Martin Schreder, Wolfgang Hübl, et al.. (2016). Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma. Leukemia & lymphoma. 57(11). 2516–2525. 18 indexed citations
6.
Ludwig, Heinz, Dejan Milosavljevic, Niklas Zojer, et al.. (2012). Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients. Leukemia. 27(1). 213–219. 78 indexed citations
7.
Lopez‐Girona, Antonia, Daniel Heintel, Derek Mendy, et al.. (2011). Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response. British Journal of Haematology. 154(3). 325–336. 137 indexed citations
8.
9.
Ludwig, Heinz, Roman Hájek, Elena Tóthová, et al.. (2008). Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood. 113(15). 3435–3442. 148 indexed citations
10.
Zojer, Niklas, Siroos Mirzaei, & Heinz Ludwig. (2008). Successful treatment of a patient with lymphocyte‐predominant Hodgkin’s lymphoma with yttrium‐90‐ibritumomab tiuxetan. European Journal Of Haematology. 81(4). 322–324. 4 indexed citations
11.
Sahota, Surinder S., Gavin Babbage, Niklas Zojer, Christian H. Ottensmeier, & Freda K. Stevenson. (2005). Determining Mutational Status of Immunoglobulin V Genes in Chronic Lymphocytic Leukemia: A Useful Prognostic Indicator. PubMed. 115. 129–144. 5 indexed citations
12.
Pecherstorfer, Martin, et al.. (2003). Current Management Strategies for Hypercalcemia. PubMed. 2(4). 273–292. 33 indexed citations
13.
Zojer, Niklas, et al.. (2002). A paraneoplastic syndrome mimicking extrauterine pregnancy. Annals of Oncology. 13(1). 170–172. 12 indexed citations
14.
Zojer, Niklas, J. C. Schuster, Jutta Ackermann, et al.. (2002). Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance. British Journal of Haematology. 117(4). 852–859. 21 indexed citations
15.
Kaufmann, H., J Ackermann, Niklas Zojer, et al.. (2001). Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases. Annals of Hematology. 80(8). 474–478. 28 indexed citations
16.
17.
Zojer, Niklas, Johannes Meran, Michael Vesely, et al.. (1999). Trisomy 13 is Associated with Poor Prognosis in Idiopathic Myelofibrosis with Myeloid Metaplasia. Leukemia & lymphoma. 35(3-4). 415–421. 5 indexed citations
18.
Schwarzmeier, Josef D., Sabine Walchshofer, Niklas Zojer, et al.. (1998). A case of bone marrow mastocytosis associated with multiple myeloma. Annals of Hematology. 76(3-4). 167–174. 27 indexed citations
19.
Ackermann, Jutta, Niklas Zojer, Heinz Gisslinger, et al.. (1998). Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undedetermined significance. British Journal of Haematology. 103(4). 1161–1163. 18 indexed citations
20.
Todt, Hannes, Niklas Zojer, G. Raberger, & Wolfgang Schütz. (1994). Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction. European Journal of Pharmacology. 265(1-2). 43–52. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Gimsing Breakdown of academic impact, for papers by Paola Omedè Breakdown of academic impact, for papers by Jatin J. Shah Breakdown of academic impact, for papers by Dixie Esseltine Breakdown of academic impact, for papers by Cristina Papayannidis Breakdown of academic impact, for papers by Michael J. Thirman Breakdown of academic impact, for papers by Sonia Fabris Breakdown of academic impact, for papers by Simrit Parmar Breakdown of academic impact, for papers by Toshiko Motoji Breakdown of academic impact, for papers by Akil Merchant
Rankless by CCL
2026